Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease
The hAβ-KI and APP<sup>SAA</sup>-KI are two amyloid models that harbor mutations in the endogenous mouse App gene. Both hAβ-KI and APP<sup>SAA</sup>-KI mice contain a humanized Aβ sequence, and APP<sup>SAA</sup>-KI mice carry three additional familial AD mutations. We herein report that the Aβ levels and Aβ42/Aβ40 ratio in APP<sup>SAA</sup>-KI homozygotes are dramatically higher than those in hAβ-KI homozygotes at 14 months of age. In addition, APP<sup>SAA</sup>-KI mice display a widespread distribution of amyloid plaques in the brain, whereas the plaques are undetectable in hAβ-KI mice. Moreover, there are no sex differences in amyloid pathology in APP<sup>SAA</sup>-KI mice. Both APP<sup>SAA</sup>-KI and hAβ-KI mice exhibit cognitive impairments, wherein no significant differences are found between these two models, although APP<sup>SAA</sup> KI mice show a trend towards worse cognitive function. Notably, female hAβ-KI and APP<sup>SAA</sup>-KI mice have a more pronounced cognitive impairments compared to their respective males. Our findings suggest that Aβ humanization contributes to cognitive deficits in APP<sup>SAA</sup>-KI mice, and that amyloid deposition might not be closely associated with cognitive impairments in APP<sup>SAA</sup>-KI mice.
Authors
- Wenyan Lü
- Guojun Bu (ORCID: https://orcid.org/0000-0003-3491-1016)
- Francis Shue (ORCID: https://orcid.org/0000-0003-1659-1952)
- Jesse R. Macyczko (ORCID: https://orcid.org/0000-0003-2847-8017)
- Takahisa Kanekiyo (ORCID: https://orcid.org/0000-0001-6751-9374)
- Suren Jeevaratnam (ORCID: https://orcid.org/0000-0001-7556-6613)
- Bhaskar Roy (ORCID: https://orcid.org/0000-0003-3604-6310)
- Ni Wang (ORCID: https://orcid.org/0000-0003-4961-7477)
- Yonghe Li (ORCID: https://orcid.org/0000-0003-3489-6362)
- Aishe Kurti
- Taha Izhar
Institutions
- Jacksonville College (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Neurobiology of Aging
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1016/j.neurobiolaging.2024.10.005
- Citations
- 6
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.96
Funders
- National Institutes of Health